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INTRODUCTIONa 
Historically the interest in organic derivatives of selenium 
has been primarily centered on selenium analogs of sulfur compounds, 
!•.!!.•• the selenium analogs of the sulfur-containing amino acids. 
Experimental studies of the metabo1ism of seleno-organic compounds have 
been limited to a large extent by their unavailability. Dimethyl 
selenide is the only organic selenium compound that has been identi­
fied as an exhalation product from a laboratory animal injected with 
an inorganic form of· selenium.1 • 
Although the toxicity of selenium has been known for many 
years, the mode of action of the element has remained a mystery. Many 
investigations on the toxicity of selenium have been concerned only 
with selenium analysis of the excreta of livestock and/or laboratory 
animals in an attempt to establish a detoxification pathway for 
selenium. Isolation and identification of excreted selenium compounds, 
with the exception of selenite or selenate_, have bee1:1 extremely diffi-­
cul t. 
A recently identified seleno�organic compound2, isolated from 
rat urine after oral and intraperitoneal administration of subtoxie 
levels of selenite, gave occasion for this study. The compound identi­
fied as a trimethylselenonium moiety was studied in the chloride formb. 
aThe writing style or· the journal Biochimica .tl Biophysica � 
was used as the guide in preparing this thesis. 
bHereafter referred to as TMSe or TMSeCl. 
This study was originally undertaken to help clarify the path­
way of selenium detoxification in the· rat by investigating the 
metabolism of the newly identified excretory product (TMSe moiety). 
A complete metabolic investigation of a selenium compound 
2 
should answer the following questions: (1) Is the compound metabo­
lized to a volatile product, at what rate is this volatile product 
excreted from the lungs, and what percentage of the administered dose 
is eliminated in this way? (2) Is it or one of its metabolic products 
excreted in the urine, at what rate is the selenium excreted, am what 
percentage.of the administered dose is excreted in the urine? (J) Is 
it or a metabolized product present in the feces and what percentage of 
the administered dose is eliminated in this way? (4) Is selenium re­
tained in t�e animal, to what degree, and what is the distribution of 
the retained selenium in the ·animal? (5) Is the compound itself 
toxic? If so, at what. selenium concentration. 
During the study of qu,estions- one and two above�- it was 
discovered that the �ompound (or a metabolized product of it) was 
itself toxic--al.though at quite high selenium concentrations--and 
further work was then done to answer question number five. 
LITERATURE REVIEW 
Since this study deals with questions one, two, and five 
brought forth in the Introduction, this literature review will be 
devoted to previous investigations concerned with answering these same 
questions for other selenium c�mpounds. 
Exhalation 
The amount of volatile selenium recovered after administration 
of various forms of selenium depends on the form administered, the 
dosage administered, dietary history of the animal, animal age, and 
the simultaneous or near simultaneous administration of protective 
agents, !_._g_., arsenic. 
Schultz and Lewis3 studied the excretion of volatile selenium 
after sodium selenite (2.5-J.5 mg Se/kg body wt.) was injected 
subcutaneously into adult male rats. They found that 1?-52% of the 
injected selenium was excreteq within 8 hours. They further found 
that the excretion of the volatile selenium co�pou.nd was not increased 
by the administration of methyl group donors such as methionine or 
choline chloride. Hofmeister4 had postulated without experimental 
evidence that one of the volatile compounds was dimethyl selenide. 
Methyl donors might be expected to assure more ready methylation of 
the selenium to dimethyl selenide. 
McConnell and Portman1. later established that dimethyl selenide 
was a volatile excretory product of selenium metabolism in the rat 
3 
after injection of sodium selenate. It has not, however, been proved 
to be the only volatile selenium excretory product. 
Using radioactive selenium McConnell5 did a study of the rate 
of selenium exhalation on rats after subcutaneous injection of a 
single subtoxic dose of sodium selenate (J-4 mg Se/kg body wt.). It 
was found that J-10� of the or'iginal dose was exhaled wi. thin 24 hours, 
and approximately 75% of this a�ount was exhaled during the first 6 
hours. 
4 
McConnell and.Roth6, examining the dose-excretion relationship, 
performed experiments to determine the correlation between the amount 
of selenium administered as either (75se)selenite or (75se)l-seleno 
methionine and that excreted in the respiratory gases. They demon­
strated that the formation and excretion of volatile selenium compo�ds 
occurs soon after the administration of (75se)selenite and (75se)l­
seleno methionine; that the rate of excretion of volatile substances 
through the �ungs when·admintstering either form is mofe rapid during 
the first 6-hours than during any subsequent 6-hour period up to 24 
hours; and on the basis of mg Se/kg. body wt., larger amounts of 
selenium are excreted when administered as inorganic than as organic 
selenium. They concluded that ·the mechanism of methylation and rapid 
excretion fil the respiratory gases_ assumes a more significant 
detoxification role when amounts of selenium approaching lethal levels 
are administered. 
The effect of dietary history on the elimination of volatile 
selenium compounds was reported by Ganther and Bauman?. They found 
that rats injected with 2.0 mg Se/kg body wt. as sodium selenite 
exhaled as much as 40� or the injected selenium within 10 hours when 
maintained on a crude diet (Purina Chow). Exhalation by rats on such 
•diets was usually about double that by rats fed a purified diet. 
Kamstra and Bonhorst8 first reported the effect of arsenic on 
the expiration of volatile selenium compounds. Rats injected with 
sodium selenite (2.5-J.2 mg Se/kg body wt.) and either J.0 or 4.0 mg 
As/kg body wt. as sodium arsenite were shown to exhale significantly 
less volatile seleniUm than when only sodium selenite was injected. 
Olson tl !1_.9 conducted an extensive study on the effect of 
arsenic on selenium metabolism in rats. Their work confirmed that 
of others7, B in that arsenite markedly reduces the exhalation of 
selenium by-rats injected with selenium at a level approaching an 
acutely toxic dose (2.0 mg Se/kg body wt.). Both arsenite and 
arsenate were found effective when injected in combination with either 
selenite or selenate. They furthe� confirmed that the ·rat is more 
efficient in �onverting selenite to the volatile form than it is in 
converting selenate� 
5 
Olson tl al.9 also showed that as the level of injected selenium 
is decreased the percentage exhaled falls off rapidly. The effect of 
arsenic injected prior to selenium injection appeared to decrease 
gradually as its level of injection was decreased, the level or 
selenium remaining constant.· 
Levander and Bauman1° in a study to determine the effect of 
arsenic on selenium metabolism found that sodium arsanilate (10 mg 
As/kg body wt. ) increased the amount of selenium eliminated .::i! the 
lungs when sodium selenite (2.0 mg Se/kg body wt. ) was injected subcu­
taneously. In the authors• opinion, this does not seem to be relevant 
to the prophylactic action of arsenic against selenium toxicity since 
the inorganic forms of arsenic which alleviate selenium toxicity 
actually inhibit selenium volatilization. 
Selenium may be eliminated by the respiratory tract in chronic 
as well as in acute selenosis. Studies dealing with the respiratory 
elimination of selenium in chronic selenosis have not been cotrlucted, 
but indirect evidence indicates that in chronic selenosis the detoxi­
fication mechanism by respiration is more active than when a toxic 
dose of selenium is given. Balance studies on selenium in chronic 
selenosis i� rats produced by 1. 4  mg Se/kg body wt. (selenite) given 
intragastrically indicate that from 50-70'%> of the administered dose 
could not be accounted. for by fecal or urinary excretion or by deposi­
tion in the tissues11. · Ther�fore, the remainder most likely was 
eliminated by the re�piratory tract·(elimination of selenium by the 
sweat glands is also known to occ�r)11 • 
Urinary Excretion 
'The factors that ai'fect the excretion or volatile selenium 
compounds also affect the urinary excretion or selenium. 
Munsell tl £.12 fed rats selenized wheat containing 9 ppm 
selenium for 6 to 11 weeks and found that from 25 to 49% of the 
ingested selenium was excreted in the urine. 
6 
7 
Smith � al..13 administered sodium selenite to cats orally and 
subcutaneously in doses of 0. 02, 0. 10, and 0. 25 mg Se/kg body wt. over 
an observation period of from 15 to 188 days. They found that from 28 
to 90%, and usually 50 to 80%, of the ingested dose was excreted in the 
urine. They pointed out, in general, that the percent excreted is 
higher for the smaller doses (0. 02 and 0.10 mg) than for the larger 
and definitely toxic dose of 0.25 mg. Also, the percent of selenium 
excreted in the urine appeared somewhat higher in animals receiving 
the selenium subcutaneously than in those receiving it orally. 
In a iater paper, Smith !i al. 14 showed that trJhen cats were fed 
selenium-containing wheat gluten the urinary excretion of selenium was 
approximately 40% of the total ingested dose (the ingestion dose being 
0. 10 mg Se/kg body wt. ). The authors, in comparing this result wit� 
that previously obtained from cats fed sodium selenite, stated that 
equivalent doses of selenium chronically administered in organic 
combination result in relatively lower concentrations of selenium in 
' . 
the urine than when administered in•inorganic form. 
This is not in agreement with results obtained by-Moxon and his 
co-workers15. They compared the ur.inary excretion of selenium by rats 
administered as seleniferous wheat, selenocystine, and sodium selenite 
(selenium content of the diet being_ 18 ppm in all rations). No 
significant difference was found in the percentage of ingested selenium 
excreted in the urine by animals on the different rations. However, 
over a six-week period the percentages increased about 50%. This 
increased selenium elimination was explained to be due either to the 
increasing age of the rats, since old rats have been found to be more 
resistant to selenium poisoning, or to physiological factors which 
limit the a.mount of selenium retained on continual administration. 
-It should be noted, however, that the two studies in question were 
done with different animals. 
McConnenl6 studied the· urinary excretion of selenium by 
injecting (?5se)sodiurn selenate (0. 25-0. ?8 mg Se/rat) in a single 
subcutaneous injection. He found that the selenium was excreted 
primarily by way of the kidneys in a nonvolatile, ether-insoluble 
form, which indicated to him that the selenium was excreted in an 
inorganic form. Forty-one to 43� of the original dose appeared in the 
urine during the first 24-hour period. 
8 
Peter.sen tl &.1? found no significant variation in urinary 
selenium excretion when ar�enic was included in the selenium diet of 
rats (1. 4 mg sodium selenite/kg body wt. plus 1. 0  mg sodium arsenite/kg 
body wt.). 1he percentage recoveri_es were very small: .. 
selenium diet 
only, 1. 5%; ·selenium-plus arsenic diet, 1. 7�. 
. . 
Ganther and Bauman? confirmed the lack of any arsenite effect 
on the urinary excretion of selenium when young adult male rats were 
injected with (75se)sod.ium selenite (1. 5  mg Se/kg body wt. ) and 2. 5 to 
2.9 mg As/kg body wt. The radioacttvity was present in tracer amounts 
only. Further, excretion Yi,! the urinary tract did not appear·to 
differ greatly when either a·purified or a crude diet was fed. Their 
results were as follows0: purified diet, 13.2/12.9�; crude diet, 
15.9/17.9% for a 24-hour period. 
Olson and co-workers9, studying the effect of arsenic on 
9 
_selenium metabolism, followed the urinary excretion of selenium by 
rats on a selenium diet (5 ppm selenium as sodium selenate). Again, 
no difference was found between a group fed only selenium and another 
group fed the selenium diet plus 0.015� arsanilic acid. Approxi­
mately 49% of the injected selenium was recovered during a 4-day 
collection period. 
The above-mentioned investigations show so many variations in 
kinds of animals used, dosages, methods of ad.ministration, and types 
of arsenic and selenium compounds used that comparisons of the results 
cannot readily be made. 
Acute Toxicity 
Acute selenium poisoning in laboratory animals is produced by 
a single toxic dose of a selenium compound administereci ·orally, 
subcutaneously, intraperitoneally,. or intravenously. 
The toxicity of selenium in different forms has been studied 
by several investigators. Rosenfeld and Beath11 have reviewed the · 
literature and tabulated the results of most investigators. An 
examination of that report shows that there is some disagreement in the 
literature on the minimum lethal dose for various animals. The 
CThese were calculated from the reported data for comparison 
purposes only and represent the average percent selenium recovered of 
the injected dose for the particular diet and for the diet plus 
arsenite. 
different results may have been due to species differences or 
variation in age of the animals. Another factor contributing to 
inconsistencies in the literature is the lack or· a standard criterion 
for minimum lethal dose. 
The relative toxicities of selenite and selenate to rats were 
compared by Franke and Moxon18• · Their results, using intraperitoneal 
injections, indicated a minimu.� lethal dose of 3.5 mg Se/kg body wt. 
with selenite and 5.J mg/kg with selenate. The term minimum lethal 
dose as defined by Fran.�e and Moxon is the dose which will kill at 
least 75<% of the animals within 48 hours. 
10 
Smith!.!:, al.19 duplicated Franke and Moxon's work and found no 
appreciable difference between the toxicity of selenite and selenate 
to rats. They did, however, observe that the action of a lethal dose 
of selenate was usually more rapid and the rats seldom survived beyond 
12 and 18 hours, while deaths from selenite were sometimes delayed for 
several days. 
As mentioned ;in the Introduction, experimental studies of the 
toxic effects of organic selenium compounds are limited. Several 
organic seleniu.m compounds have been tested as to their acute toxic 
effects20,21, 22• Of most importance are the selenium analogs of the 
sulfur-containing amino acids. The minimum lethal dose of dl­
selenocystine injected intraperitoneally was investigated by Moxon21 
and found to be 4. 0 mg Se/kg-body wt. Subsequent work by Moxon 
tl al.23 showed that 1-selenocystine was more toxic than the d-form 
when given orally and that arsenic gave full protection against the 
11 
toxicity of the analogs just as it does against the toxicity of the 
selenium in seleniferous grains. From these results, they concluded 
that selenocystine is one of the more important, if nQt the most 
important, carriers of selenium in seleniferous cereals. The minimum 
lethal dose of selenomethionine by intraperitoneal injection in rats 
was found to be 4. 25 mg Se/kg .body wt. 23. 
Investigations as to the acute toxic effects of dimethyl 
selenide indicate that it has a low degree of toxicity.in the rat. 
The LD50 by intraperitoneal injection is 1.6 g Se/kg body wt.24. 
These workers concluded that detoxification of selenium in the animal 
body proceeds from a highly toxic form to a less toxic compound which 
is eliminated through the respiratory tract. 
Acute toxicity of elemental selenium has not been investigated 
in detail. Rosenfeld and Beath11 concluded that elemental selenium 
is not toxic owing to its relative insolubility. 
In explaining the mechanism of acute selenium toxicity some 
workers have postulated that certain key enzymes are inhibited. In -
this regard, Klug ll al� 25 investigated the effect of a number of 
seleno-compounds on the activity of succinic dehydrogenase of rat liver 
homogenates. Of a series of seleno-compounds, selenocystine was the 
most toxic and selenomethionine the least toxic. There was no correla­
tion between the degree of enzyme inhibition!!!, vitro and the toxicity 
of seleno-compounds in intact animals •. 
A complete description of the symptoms of acute selenium 
poisoning in the rat does not appear in the literature. The following 
12 
summarized description is from Franke and Moxon18• Within a few 
minutes after injection of selenate or selenite the rats began to 
exhale odoriferous compounds in the breath. Rats injected ld th 
selenite usually exhibit spasmodic contraction of the flanks from time 
to time and appear· to be in acute distress during the contractions. 
With larger doses respiration becomes increasingly difficult and the 
rats become cyanotie and die gasping for breath. In some cases there 
appears to be a complete anesthesia just before death while in others 
there is a convulsive struggle. Symptoms caused by injecting selenate 
resemble quite closely those caused by selenite. 
Gross pathological data on acute selenium poisoning in 
laboratory animals are not very extensive. Jones26 described the liver 
as being soft and pliable, the right auricle of the heart distended and 
full of clot, and the splanchnic ve�sels enormously dilated. 
Chronic Toxicity 
Chronic sel.enium poisoning _in laboratory animals may be 
produced by the administration of small repeated doses over a long 
period of time. The selenium may be given orally or by intraperitoneal; 
intramuscular, or subcutaneous administration. The poisoning may be 
produced by using inorganic selenium compounds, natural seleniferous 
grains or plants, or artificially �elenized crops grown in soils 
treated with selenium salts or with seleniferous plant extrao-tsll. 
There is considerable individual variation in susceptibility to 
the toxic effects of selenium. In chronic selenosis the effects of 
selenium are cumulative. Cumulative effects of irrli vidual doses may 
13 
be produced by 16-50% of the minimal lethal dose. The wide range is 
due to individual variations in susceptibility and not to lack of 
absorption or excretion, as the same variations exist when selenium is 
_injected intravenouslyll. The comparative results of all studies 
indicate that individual variations must be related to some detoxi­
fication mechanism which functions with greater efficiency in some 
animals11 • 
On repeated administration of ch:ronic doses of selenium there 
is a continual increase in the manifestation of the disease which 
suggests that there is no altered susceptibility or acquired tolerance 
which would account for individual variations. In addition to 
individual variations, there is a difference in susceptibility with 
age. Younger rats are more susceptible to selenium than older animals. 
The life span of younger animals is greatly reduced while older animals 
fail to gain weight. Small differences in age and weight of animals 
may have a greater effect on susceptibility than the possible differ-. 
ences in the toxicity of the compound testea11 • 
Franke
.
and Painter27, in a study which included the feeding of 
many different seleniferous diets to rats, made the following 
conclusions: (1) If selenium was the only toxicant in the diets, ·the 
relative toxicity of selenium in the different forms is (from highest 
to lowest): wheat, corn, barley, selenate, and selenite. (2) There 
is a pronounced restriction of food consumption in every diet contain­
ing over 10 ppm of selenium as it occurs in the diet. (3) Concentra­
tions of less than 5 ppm of selenium in the diet are sufficient to 
2 3 3 o.5 G SOUTH DAKOTA STATE U1 VER ITY LIBRARY 
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prevent normal growth. (4) In general, 9 ppm of selenium cause deaths 
in young animals. Further, it is probable that on1y naturally 
occurring selenium will regularly cause deaths at this level. 
(5) Female rats are slightly more susceptible to selenium poisoning 
than males. (6) There is no relationship between the absolute amount 
of selenium consumed per day and observed toxic effects. The effect 
of seleniferous diets appears to depend more on the concentration of 
selenium in the diet than upon the quantity of selenium consumed per 
day. '!his same paper also substantiates the fact that the toxic 
manifestation of inorganic selenium compounds and seleniferous grains 
are almost identical under similar experimental conditions. 
Moxon28 was the first to observe that arsenic prevents the 
characteristic symptoms of selenium poisoning in rats. In experiments 
to determine the toxicity of selenium in combination with several 
other elements, he found that the addition of 5 ppm arsenic as sodium 
arseni te to the drinking water gave ·· full protection against liver 
damage caused by 15 · ppm of selenium in the fom of seleniferous wheat.­
He also found that arsenic protected against liver damage and the 
general toxic effects of inorganic selenium. 
Moxon tl al.29 disprove� the theory that arsenic protects 
against selenium toxicity in inhibiting the absorption of selenium from 
the gastrointestinal tract by demonstrating that detoxification was 
independent of the route of administration of either selenium or 
arsenic. 
15 
Chronic selenosis in rats is characterized by marked loss in 
body weight and anorexia followed by eachexia. Ascites and edema may 
develop under identical conditions. Ascites and edema also may develop 
after the discontinuation of small chronic doses of selenium, provided 
the duration of administration is sufficient to produce damage to the 
liverll. 
The gross pathological changes due to chronic selenium poisoning 
depend upon the duration and dose of the toxic substance. In the truly 
chronic· cases the outstanding pathology occurs in the liver. The 
liver is hard, nodular, and shrunken in size, showing nodular 
cirrhosis. Varying degrees of atrophy and necrosis are present. 
The heart and spleen are enlarged. Jaundice may or may not be 
present. The thymus and gonads show atrophy. Ascites and edema are 
commonll. 
Trimethylselenonium Production 
Palm._er tl .2:1• 2, during their work t.o identify �Se, studied the 
effect of level of -selenite on the.production of TMSe and a.lso the 
effect of sodium arsenite on its production. They concluded that 'flv1Se 
is a normal metabolite because it is.excreted at both low and high 
levels of selenium (2 micrograms Se and 0.8  mg/kg body wt. ).  To 
further substantiate their conclu�ion, they had evidence that TMSe is 
an important excretory product whether selenite was administered orally 
or by injection. They found a statistically significant effect of 
arsenite on the production of TMSe only at . the higher level of selenium 
used in their experiment (0. 8  mg Se). At this level of selenium plus 
16 
2 mg As/kg body wt. they found that significantly less (P <0.05) TMSe 
was produced. Because they did not get this statistical significance 
. . 
at the lower level, they suggested that there was still some doubt as 
to the effect of arsenic on TMSe production and that higher levels of 
selenium should be· administered before final. judgment is made. 
This study examined th� fate of TMSeCl in relationship to its 
metabolism to a volatile product. The study al.so examined both the 
acute and chronic toxicity of TMSeCl. Finally, the effect of arsenite 
on the production of TMSe from selenite on the volatilization of 
selenium from TMSeCl and on the toxicity of TMSeCl was investigated. 
17 
EXPERIMENTAL PROCEDURES 
Materials 
The rats used in the various experiments were all males of the 
Sprague-Dawley strain. They were all fed Purina rat chow until placed 
on-experiment. The rats when used in experiments involving injection 
into the peritoneal cavity were starved overnight--approxi.m.ately 18 
hours. The radioactive selenium used was obtained from Nuclear Science 
in the form of H275seo3. Analytical reagent grade sodium arsenite was 
used. The sodium selenite was prepared and purified according to the 
procedures of Trelease and Beath30. Its analysis indicated a high 
degree of purity. The basal diet used in the chronic toxicity study 
contained the following in percent: dextrose, 67. 8; purified casein, 
20. 0; corn oil, 5. 0; USP salt mixture, 5. 0; and vitamin mixture, 2�2• 
The TMSeCl was prepared by refluxing dimethyl selenide with methyl 
iodide. The TMSeI fomed was run through a Dowex 2 chloride-form anion 
exchange resin column to exchange a chloride ion for the iodide ion. 
The TMSeCl ·collected was recrystaliized 3 times from methanol. 
Selenium analysis of the TMSeCl, using the Watkinson method31, 
indicated the compound was 99% pure. · NMR spectra indicated no organic 
contamination. The dimethyl selenide was prepared according to the 
procedures of Bird and Chil.lenger3�. Dimethyl sulfide used in prepara­
tion of trimethylsulfonium chloride was prepared according to 
procedures outlined by ReidJ3. 
Exhalation Study 
F.quipment used to house the rats while collecting exhaled 
selenium consisted of an opaque wide mouth jar of about 4 liters 
volume. The jar was connected to an all-glass absorption bottle. 
The bottle was fitted with a sintered glass inlet and contained 175 
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ml of concentrated nitric acid. The absorption bottle was in turn 
connected to a vacuum source adjusted to draw air through the system 
at the rate of 800 ml/min. Preliminary work indicated one absorption 
bottle �as sufficient to trap the volatile selenium. All connections 
were of glass or tygon tubing with the exception of a two-hole rubber 
stopper which covered the mouth of the opaque jar. A piece of glass 
tubing extending through the rubber stopper and to the bottom of the 
jar provided the air supply. Three such systems were built and used 
at random on different days with rats injected with various doses of 
TMSeCl. This was done to· insure that the effect observed was 
attributable to the treatment appli·ed and not the result of any 
uniqueness of a· particular system .or day-to-day environmental changes. 
. . . 
To determine whether there was a diffe�ence in the amount and 
rate of selenium exhaled when rats were injected with TMSeCl as 
compared to selenite, rats were injected intraperitoneally with sodium 
selenite or TMSeCl at levels ranging from 1. 5-40.0 mg Se/kg body wt. 
To determine whether or not arsenic affects the volatilization of 
TMSeCl selenium, sodium arsenite was injected intraperitoneally 10 
min. prior to the selenium at either · 2 or 4 mg As/kg body wt. The 
rats ranged in weight from 143 to 277 g with an average weight of 189 
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g. Immediately after the selenium injection, the rats were placed in 
the jars and the collection of volatile selenium was started. At 1, 
J, and 6-hour intervals 15 · m1 aliquots were removed .from the 
absorption bottles and analyzed for selenium by the Watkinson method. 
Acute Toxicity Study 
During the course of the exhalation study it was discovered that 
TMSeCl was toxic if injected at high selenium levels. An experiment 
was performed in which 30 rats averaging 138 g were divided into 5 
groups of 6 rats each. Each group was injected with a different level 
of Se/kg body wt. The levels used were 40 , 45 , 50 , 55, and 60 mg Se/kg. 
These levels were used since preliminary work indicated the LD5o lay 
between 40 and 60 mg Se/kg. Toxic symptoms and gross pathology of those 
rats which died were observed .for comparison with the symptoms and 
pathology associated with selenite and selenate toxicity. 
Chronic Toxicity Study 
Two experiments were conduc�ed with weanling · rats to de�ermine­
the effect of feeding TMSeCl. Rats were randomly assigned to a 
particular group except that certain adjustments were made to obtain an 
approximately equal average w�ight for each group. The animals were 
housed in individual. stainless  steel cages in an air conditioned room,  
given food and water � libitum throughout the experiment, and weighed 
at weekly intervals. 
The purpose of experiment 1 was to determine if TMSeCl could 
produce chronic selenosis. Twenty rats (50-60 g) were divided into 
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4 groups of 5 rats each. Group 1 served as a basal diet control and 
received only the basal diet. Group 2 served as a standard for 
comparison of selenium toxicity and received the basal diet plus 9 ppm 
selenium as sodium selenite. Group 3 received the basal diet plus 9 
ppm selenium as TMSeCl. Group 4 received the basal diet plus JO ppm. 
selenium as TMSeCl. The experiment was terminated at the end of the 
fourth week. At that time all rats were killed and the livers removed 
and weighed. Gross pathology of the rats was again observed and 
· comparis·ons made between the various groups. 
The purpose of experiment 2 was to determine the repeatability 
of experiment l and, in addition, to study the effect of adding arsenic 
to the diet of rats fed ™SeCl. This experiment consisted of 6 groups 
of 5 rats (40-50 g). Group 1 served as the basal diet control. Group 
2 served as the standard for selenium toxicity and received the basal 
diet plus 10 ppm sele�ium as sodium selenite. Group 3 received the 
basal diet plus 10 ppm - selenium as TMSeCl. Group 4 received the basal 
diet plus 3_0 ppm selenium as TMSeCl_. Group 5 served · as the arsenic 
control and received the basal diet plus 10 ppm arsenic as sodium 
arsenite. Group 6 received the basal diet plus 30 ppm selenium as 
TMSeCl and 10 ppm arsenic as sodium arsenite. The experiment· was 
conducted exactly as experiment l in all respects with the exception of 
the slightly higher selenium levels. 
Urinary Excretion Study 
This study was an extension of �he study reported by Palmer 
tl !1,.2 and was designed to determine whether arsenic affects the 
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urinary excretion of TMSe by rats receiving relatively high levels of 
sodium selenite. Two groups of 6 rats each averaging 137 g were used. 
The control group was injected with a single dose of radioactive 
selenite by intraperitoneal injection. Each dose contained approxi­
mately 100 microcuries of radioactive selenium (H275se03) and 
sufficient carrier sodium selenite to equal 2 mg Se/kg body wt. The 
second group received the selenium injection, but in addition they 
received an intraperitoneal injection of sodiu.s.� arsenite (4 mg As/kg 
· body wt. ) 10 min. prior to the selenium injection. After injection, 
the rats were placed in stainless steel metabolism cages and urine was 
collected at 8-hour intervals over a 24-hour period. No food was given 
during the collection period, but tap water was available _!2, libiturn. 
The amount of TMSe excreted was deter�ined by subjecting aliquot 
portions (30-50 microliters) of 75se-containing rat urine to two­
dimensional paper chro�atography on Whatman No. l paper (46 cm X 57 
cm). The paper was developed in the: first dimension with phenol-water. 
(73: 27 w/w) and in the second dimen�ion with n-butanol-acetic acid­
water (4:1:1, by vol. ) .  The radioactive TMSe metabolite was located 
on the paper by cochromatographing approximately 20 micrograms of known 
TMSeCl with the urine aliquot. The known TMSeCl was then located by 
spraying the paper with the Munier and Machenhoeuf modific�tion of 
. 2 
Dragendorf' s Reagent34 as described by Palmer � al • • The colored 
spot obtained (a pinkish orange) was then cut from the paper and 
counted in a Packard well-type· scintillation counter. Total 75se in 
the urine was determine� by counting aliquots of each sample. 
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RESULTS 
Exhalation Study 
'Ihe results in Table I and Fig. 1 show that the amount of 
exhaled selenium is very much less when selenium is injected as ™5eCl 
than when injected as sodium selenite. 'lhe data also show that as the 
selenium level, as Ti�SeCl, is increased the percentage of selenium 
exhaled increases for a time but then begins to decrease as the level 
of selenium approaches an acutely toxic dose (see section below on the 
acute toxicity of TMSeCl) . 
In the cases where the level of selenium is relatively low and 
in cases where selenium levels are near the acutely toxic level, there 
appears to be a cessation of the exhalation of volatile selenium 
between J and 6 hours. At intermediate levels exhalation of volatile 
selenium continues even up to 6 hours, but the rate of production of 
the volatile compound(s) decreases continuously. 
Table I and Fig. 2 show the. effect of sodium arsenite on the 
exhalation of selenium • . Althoug� the rats did not live 6 hours at the 
levels injected (because of the synergistic effect of arsenite on 
TMSeCl toxicity), the results indicate that arsenite increases the 
exhalation of selenium. At least at low levels of selenium this is 
apparently true . The level of arsenic injected at constant selenium 
levels also affects the percentage of selenium exhaled. 
Table I. Selenium Exhalation by Rats Following Injection of TMSeCl and Effect of Simultaneous 
Injection of Sodium Arsenitea. 
Selenium In,jection Dosage Selenium Exhaled (%  injected dose) 
mg Se/kg mg Nl/k g Injection Hours after injection 
Form body wt. body wt'. 1 2 3 
. Selenite 1.5 6. 7 19 . 5 
TMSeCl 1.5 1.9 3 . 5 
TMSeCl 15. 0 3. 2  6.2 
TMSeCl 30 . 0 1 .9 4.9 
TMSeCl 40. 0  1. 3b 2.4C 2.9 
TMSeCl 0.75 2. 0 13. 4c 
TMSeCl 1.5 2.0 4.5 
TMSeCl 1.5 4. o 6.8 
TMSeCl 40. 0 4. 0 l.ld 
a Data are averages for three rats unless otherwise indicated. 
b Datum is average for five rats. 
c Data are averages for two rats. 
d Data for only one r_at. 
7.4d 
12.3° 
J.8d 
4 
3.9c 
8.ld 
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Fig. 1. Selenium exhalation by rats following injection of TMSeCl. 
• 1.5  mg Se/kg body wt • 
* 0. 75 mg Se/kg body wt. + 2. � mg As/kg body wt. 
• 1. 5 mg Se/kg body wt. + 2. 0 mg As/kg body wt. 
0 1 .5  mg Se/kg body wt. + 4. o mg As/kg body wt. 
D 40. 0 mg Se/kg body wt. + 4.o mg As/kg body wt. 
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Fig. 2 .  Effect of sodium ars_eni te on the exhalation of selenium 
following TMSeCl injection. 
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Acute Toxicity Studl 
The results of Table II indicate that the approximate LD50 of 
TMSeCl for the rat is 48 mg Se/kg body wt. The symptoms of TMSeCl 
poisoning observed after injection of an acutely toxic dose were very 
nearly the same as those described by Franke and Moxon18• The gross 
pathology of dead rats was similar to that described by Jones26. The 
pliable liver condition was hard to evaluate, however. Not all rats 
showed the same symptoms or pathology nor did they all show the 
symptoms and pathology to the same degree. 
As mentioned above, arsenite was found to exert a synergistic 
effect on TMSeCl toxicity_. This is in conflict with what has been 
reported for other forms of selenium. To the author ' s  knowledge, this 
is the first report of the synergistic effect of arsenite on selenium 
toxicity. kn LD50 determination for rats injected with various levels 
of TMSeCl plus 4 mg As/kg body wt. was carried out. The results are 
given in Table III. The approximate LD50 was found to be 9.7  mg Se/kg 
body wt. There · is ·evidence to suspect that this value · may vary with -
the level of arsenic injected. The arsenite injections preceded the 
selenium injections by 10 min. 
The criterion used for _ the determination of the LD50 in either 
case was the level of seleniu.� that would cause death to 50% of those 
injected in 4 hours. It is important to note that the rats injected 
with only TY!SeCl died soon (within 1 hour ) after injection or not at 
al.l. The rats injected with TMSeCl plus arseni te very seldom died 
before 1 hour. Once they beg_an sho·wing the toxic Symptoms they lived 
Table II. Calculation of LD50 of TMSeCl for the Rat by the Dragstedt 
Methoda. 
Dose 
Results in 4 Hours Cumulative 
27 
mg Se/kg 
body wt. Lived Died Lived Died f, Mortality 
40 6 0 13 0 o . oo 
45 5 l 7 1 12 .5 
50 2 4 · 2 5 71 .5 
55 0 6 0 11 100 
60 0 6 1 17 100 
a This method has often been attributed to Reed and Muench35, ·who 
devised a �imilar procedure. The method was actually worked out by 
Dragstedt:36• 
Table III . 
Rat. 
Dose 
mg Se/kg 
body wt.a 
Effect of Sodium Arseni te on the LD50 of TMSeCl for the 
Results in 4 Hours 
Lived Died 
2 4 
4- 2 
3 J 
4 2 
3 J 
Cumulative 
Lived Died 
16 . 4 
14 6 
10 9 
7 11 
J 14 
'%,_ Mortality 
20. 0 
30. 0  ,. 
47.5  
61. 0 
82.-4 
a Intraperitoneal injection of 4. 0 mg As/kg body wt. preceded the 
TMSeCl injection by 10 min. 
only 10-15 min. longer, however .  In addition to the gross pathology 
observed for rats injected with TMSeCl, those rats that died from the 
TMSeCl plus arsenite injections showed what appeared to be massive 
hemorrhaging in the lungs. 
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The method used to establish the LD50 did not permit an estima­
tion of the accuracy of the answer �alculated36• It is the opinion of 
this investigator that this information would be of no practical val�e. 
The value of the LD50 for TMSeCl is sufficiently different from that 
obtained for TMSeCl _plus arsenite that no statistical analysis is 
necessary to prove a treatment effect. This same reasoning can be 
applied when one compares the LD50 value for TMSeCl with the LD50 
values that could be predicted for selenite or selenate . 
Chronic Toxicity Study 
The data in Table IV summarize the results of feeding TMSeCl 
and the effect of adding sodium arsenite to a diet containing T}!SeCl. 
In neither experiment is there a significant difference in weight gain 
or liver wt. /100 g body . wt. betw�en the control group and the groups 
receiving diets other than those containing selenite (as determined 
by Dunnett' s test37). No gross pathology was observed in any rats, 
with the exception of the selenite-fed rats which showed the 
characteristic liver necrosis, jaundice, and in some cases anemia 
associated with chronic selenosis. 
At the levels of selenium and arsenite used, W.LSeCl was not 
toxic when ingested orally and there was no synergistic effect when 
arsenite was added to a diet containing TMSeCl. 
. Ji 
Table IV. Chronic Toxicity or TMSeCl and Effect of Added Sodium Arsenite. 
Bodl Weighta 
First Second Third 
Treatment Start W:eek Week Week 
Experiment l 
Basal diet 58. 0±4.2b 77�7±8.7 113.0±14.4 157.2±17.1 
Basal diet+9 ppm Se 58.3±2.2 58.0:tJ.2* 74.2± 6.1* 99 -7± 7.1• 
as selenite 
Basal diet+9 ppm Se 57.1±2.0 78.2±3-.5  lll.9:t 9.8 146.3:rl8.3 
as THSeCl 
Basal diet+J0 ppm Se 55.6±1-7  73 -3±2.6 105.9± 4. 6 149.2:t 1.3 
as TMSeCl 
Experiment 2 
Basal diet 49 -5:r2�3 76�2:t6. 3 111.3:t 9.3 155.7:t-16.o 
Basal diet+l0 .PPM Se 48.9:t.-l.9 47.3:t.5 - 3 *  58.8:r 6.6* 78. 5:t 9. 8*  
as selenite 
Basal diet+l0 ppm Se 48.7:t-2.8 75.2:tJ.6 112. 3:t 7.9 156.6± 9.4 
as TMSeCl 
Basal diet+J0 ppm Se ,50.2:H.9 76.6±1. 6 113.6:t- 4.6 154.3:t 8. 8 
as TMSeCl 
Basal diet+l0 ppm As 49.5:rl.3  7602:tJ. 4 ll4. 6t 4.8 156.7:t 7.9  
as arsenite 
Basal diet+J0 ppm Se 50.5:t2.2 77.1:tJ • .5 109.0:t 6.8 149.6±11.0 
as TMSeCl+l0 ppm 
As as arsenite 
Fourth 
Week 
196. 6:t22.8 
127.l:tl5. 0* 
185.l:t20. 8  
187.7+ 3. 6 -
202.8±21 • .5 
91. 6:t21.0*0 
204. O:rl2. 6. 
199. 3:tl0.5 
201. 3:t 6.9 
192.2zlJ. 4  
� Represents average of five rats unless otherwise indicated. Weights in g. 
Mean:tstandard deviation. 
Liver Weighta 
per 100 g 
body wt. 
4.2LH--0.16 
3. 36t().95* 
4.33±0.31 
4.55:t0.17 
.5 - 53±().48 
J.22:tl.2J*C 
5♦ 75:t0- 27 
5.97±().51 
5.19:r0.52 
5. 67!t(). 82 
c Represents average of four rats. One rat died two days prior to termination of experiment. 
* Significantly different from the basal diet group (P  <0. 05 )  by Dunnett ' s test37. 
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Urinary Excretion Study 
The data in Table V indicate that the group receiving selenite 
plus arsenite excreted a lesser amount of 75se than did the group 
receiving only selenite. The difference was highly significant as 
determined by 1 1t 1 1 test37. The data also indicate that a significantly 
lesser amount of 75se in the form of TMSe was excreted for the group 
receiving selenium plus arsenite than for the group receiving selenite 
alone, again as determined by "t" test. 
Fig. J shows clearly that the significantly different results 
are· observed only in the first 8-hour period. Later time periods 
showed no significant difference in the results for the two groups. 
The 8-hour period differences were large enough so that a statistically 
significant difference was obtained over the entire 24-hour collection 
period when the data were combined. 
Table V. Effect of Sodium Arsenite on the Urinary Production of TMSe From Rats- Injected With (75se) 
Selenitea. 
Collection % 75se recovered in the urine Interval 
Hours In the form of TMSe Of the injected dose 
After % of urinar;y: Se � of in,jected dose 
Se onlyb Injection Se+Asc Se only Se+As Se only Se+As 
Rate Study 
0-8 10.5+1.4d ?. O:tl.l** 42. 2±11. 6 40. 3±4.0 4.4to.9 2. 8t0.2** -
8-16 6.11:1.0 5.4±0. 7 40. 3± 5 .9 40. 6±2.4 2.4-zo.4  2. 2±0 - 3  
16-24 4.5:tO .-5 4.7±<)�8 35.J± 5.4 31.0±2.8 1. 6±0.2 1. 5:ta.4 
Totals 
0-8 10. 5±1.4 7• 0±1.l** 42.2±11. 6 40. 3±4.0 4.4to.9 2.8±().2 ** 
0-16 16. 6,zl.9 12.4±1.6** 38. 8± 2. 8 38. 0±2. 8 6. 8:tl.2 5.0:t<). 6** 
0-24 21.2±1.9 17.2±1. 6** 37-5± 7.2  35- 5±1. 9  8.4±1. 3  6.5±0. 6* 
a Averages for six rats. · 
b 100 microcuries 75se and additional· sodium selenite to make injection dose of 2. 0 mg Se/kg 
body wt. 
� Dose of 4.0 mg A:3/kg body wt. preceded the selenite injection by 10 min. 
Mean+standard deviation. 
* Sig;ificantJ.y different from the selenite only group (P <0. 0.5) by 1 1t" test37. 
** Highly significantly different from the selenite only group (P<0.01). 
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o Se recovered when selenite only injected. 
• Se recovered when selcni te .t,4 arseni te injected. 
c Se · .  as TMSe recovered when seleni te only injected. 
a Se as TMSe recovered when seleni to + arseni te injected. 
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Fig. J .  Effect of sodilL� arsenite on the rate o f  urinary excretion of 
selenium and on the rate of urinary excretion of THSeCl.  
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DISCUSSION 
The level at which TMSeCl is toxic is high rel a.ti ve to that 
reported for other forms of selenium, i•�• , MLD for selenite and 
selenate is 3.5 mg and 5. 3 mg, respective1yl8 , MLD for dl-selenocystine 
and selenomethionine is 4.0 mg and -4.25 mg , respective1y22, 23. If one 
were to postulate that the toxicity of these compounds is due to their 
conversion to the TMSe moiety, then one must also postulate that they 
all go through a common intermediate on their way to conversion to 
TMSe. If this were not true, then one should observe a greater degree 
of variation in the toxic dose of each. Further, ·there must be a rate­
limi ting step in the pathway, either the formation of this postulated 
intermediate itself or a step between the common intermediate and 
TMSe. A question immediately arises--if TMSe moiety is the toxic 
substance involved for all of these compounds, why is it necessary to 
inject TMSeCl at such high levels in order to get a toxic response? 
The proof of this hypothesis· will have to provide the · answer to this 
question. 
The synergistic effect of arsenite on TMSeCl is in direct 
opposition to what has been reported for other forms of selenium. It 
is the belief of this investigator that the observed results are a 
synergistic effect and not a summation effect because the toxic 
symptoms for rats injected with TMSeCl plus arsenite are the same as 
those observed when TMSeCl is injected alone. Since the mechanism by 
which arsenic exerts its effect on selenium metabolism is unknown, one 
cannot say with certainty that it is exerting itself differently 
when Tl'1SeCl is injected than when selenite is injected. 
After completion of the toxicity studies for TMSeCl, it was 
. thought necessary to compare the toxicity of TMSeCl with trimethylL 
sulfonium chloride ( TMSCl ) to verify that the observed toxicity was 
J4 
in fact due to the unique presence of selenium and not to a particular 
chemical structure, i•�• • the trimethyl -onium structure. Injection of 
TMSCl in the same manner as TMSeCl produced the same toxic symptoms and 
death as observed fo.r TMSeCl. Arsenite was also found to have the 
same synergistic effect on THSCl as it has on TMSeCl. Hunt and 
Renshaw38 studied the effect of trimethylsulfonitun iodide (Tl1SI ) on 
the autonomic nervous system of cats and found that TMSI has both 
muscarinic and nicotinic action. Their criterion for muscarinic 
action was taken as a fall of blood pressure which was prevented by 
small doses of atropine (but not by nicotine or by section of the 
vagi ) .  Their criterion for a nicotinic action .. ,as taken as  a rise of 
blood pressure with� frequently, an acceleration of the heart in an 
animal in which the brain· and uppe� spinal cord had been _ destroyed and 
which was prevented by a large dose of nicotine but not by atropine. 
The approximate fatal dose of TMSI for mice was found to be 33 mg S/kg 
body wt. Muscarine, from which the term muscarinic action gets its 
name, exerts effects very similar to those of acetylcholine on smooth 
muscle, cardiac muscle, and.exocrine glands
39. Sollman40 in describing 
the action of muscarine on the frog heart states that muscarine causes 
slowing, with diminished systolic and increased cliastolic excursions, 
35 
and finally stoppage in diastole. Muscarine is reported to cause 
acute excitement and violent delirium40. Nicotine, from which the 
term nicotinic action gets its name, has both centrol. nervous system 
and peripheral actions, both of which are important. Cen�rally, small 
doses cause chiefly a respiratory stimulation ; larger doses produce 
·-
convulsions of the medullary type and arrest of respiration. The 
action is rapid, approaching that of hydrocyanic acid. Peripherally, 
nicotine paralyzes all autonomic ganglia, parasympathetic as well as 
sympathetic. The paralysis may be preceded by stimulation. Nicotine 
has several distinct actions on striated muscle, including fibrillary 
twitchings, curare action, and tonus40. 
Because the symptoms of TMSeCl toxicity and the gross pathology 
of dead animals are compatible with what one could predict for compounds 
having muscarinic a:nd/or nicotinic action and, since TMSI has been 
proved to have these �roperties, it seems credible that TMSeCl toxicity · 
may be due to these same actions. This investigator proposes that this 
may be the case and that TMSeCl toxicity may not be caused by the 
unique presence of selenium but rather may be a general property of 
most compounds with that same general structure. It is .also possible 
that the toxicity of selenite--and, indeed, a.11 foms of s�lenium--is 
due to the formation of the TMSe moiety because the symptoms and 
pathology are similar. 
This explanation whi�e answering -some of the questions that have 
arisen from the voluminous data on selenium metabolism does not answer 
them all. In fact, several factors are still unexplainable, !.•.!• •  the 
effect of arsenic on selenium metabolism. This , in itself, does not 
disprove the proposal given. The establishment or ' the metabolic 
pathway, including the enzymology, may confirm this theory. 
J6 
The theory does provide a basis for explaining the very low 
exhalatio11 of volatile selenium when TMSeCl is injected as compared to 
selenite. If TMSeCl is assumed to have the nicotinic action of TMSI, 
then a large dose would suppress respiration, thereby decreasing 
exhalation of volatile selenium. On the other hand, if one assumes 
that the volatile selenium product( s) is on the pathway to TMSe pro­
duction, then the nonreversibility of the step( s )  leading from 
volatile product( s) to TMSe could alone explain the lowering of volatile 
selenium. This latter explanation is satisfactory up to a point, but 
one then wonders why this nonreversibility manifests itself less  at 
40. 0 mg Se than at JO. O mg or 15.0 mg. If formation of volatile 
selenium from TMSe is a spontaneous process, logic ·would predict that 
more volatile product would be formed if a higher dose is injected. 
. . 
The propos�d theory offers a better ex:plan.ation for ·the observed data� 
!_._g. , a rise in volatile ·selenium as the level of selenium increases up 
to 15. 0 mg Se and then a decrease. The depression of respiration would 
be greater the larger the dose. of TMSeCl. The apparent cessation of 
exhalation of volatile selenium at 1.5 mg Se may not be a result of the 
proposed nicotinic action. Tsay1U working with radioactive T�eCl at 
0.1  mg Se/kg body wt. found _that the major fraction of the TMSe was 
excreted in the urine. Therefore, at low levels TMSe may be e�creted 
fast enough to reduce volatilization. At higher levels ,  renal 
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excretion may not operate rapidly enough and thus increased volatiliza­
tion would occur up to the point that TMSe inhibits respiration. 
An explanation for the failure of TMSeCl to show toxic effects 
when given orally is that the compound may not be absorbed from the 
digestive tract. Additional work in this area is necessary to verify 
the validity of this hypothesis . 
The biological significance of the decreased TMSe production 
from rats injected with selenite plus arsenite is doubtful. The results 
are statistically significant , but this is probably not of any real 
value in explaining the decrease in selenite toxicity by arsenite since 
the magnitude of the differences was rather small . The similar decrease 
in urinary selenium is itself sufficient explanation for the decreased 
TMSe observed. 
The effects of arsenite on exhalation and toxicity are particu­
larly hard to explain as they are exactly opposite to what has been 
reported for other forms of selenium. studied. Arsenite was also found 
to increas� the toxicity of dimethyl selenide as much as 200-fold 
(unpublished data of this investigator). The discovery of the 
mechanism of action of arsenic on selenium metabolism will surely do 
much to elucidate the pathway of selenium. 
This investigation did not study the complete metabolism of 
T11SeCl. Further studies should include fecal elimination and body 
retention studies. Such studies should. provide evidence of the 
validity of the proposal made as to TMSeCl toxicity. 
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SUNMARY 
Trimethylselenonium chloride is toxic to rats when administered 
by intraperitoneal injection but at much higher selenium levels than 
required for selenite. The LD50 is 48 mg Se/kg body wt. The toxic 
symptoms and gross pathology are very similar to those produced by 
selenite. The hypothesis was suggested that the toxicity of TMSeCl may 
be due to a muscarinic and/or a nicotinic action which similar compounds, 
i•!:.•, trimethylsulfonium iodide, have been shown to produce. When 
administered in the . diet at levels up to JO ppm TMSeCl is not toxic. 
TMSeCl is not metabolized to a volatile product(s) as readily 
as selenite. This implies that exhalation probably is not an important 
route of excretion for the removal of this toxic material from the 
body. The ·effect of arsenite on TMSeCl metabolism is exactly opposite 
that reported for other forms of selenium. Arsenite increases the 
toxicity of TMSeCl. °This was a.lso found to be true for dimethyl 
selenide. �he LD50 for TMSeCl Elus arsenite ( 4. 0  mg As/kg body wt. ) 
is 9. 7 mg Se/kg body wt. Arsenite also increases the exhalation or· 
volatile selenium compound(s) after TMSeCl injection. Arsenite does 
not have a synergistic effect on TMSeCl toxicity when both are given 
orally as dietary supplements. Arsenite lowers the urinary production 
of TMSeCl by rats administered selenite by a statistically significant 
amount. It is doubtful that this is of _ any real value in explaining 
the protective effect of arsenite against selenite toxicity as the 
differences are not large. 
Additional experiments to include fecal and re tention studies 
are nece s s ary to con1pl ete the inve stigation of the metaboli sm of 
TMSeCl. 
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